Explore: Sanofi Aventis (firm)
Discover books, insights, and more — all in one place.
Learn more about Sanofi Aventis (firm) with top reads curated from trusted sources — all in one place.
AI-Generated Overview About “sanofi-aventis-%28firm%29”:
Books Results
Source: The Open Library
The Open Library Search Results
Search results from The Open Library
1Staff report on Sanofi's strategic use of third parties to influence the FDA
By United States. Congress. Senate. Committee on Finance
“Staff report on Sanofi's strategic use of third parties to influence the FDA” Metadata:
- Title: ➤ Staff report on Sanofi's strategic use of third parties to influence the FDA
- Author: ➤ United States. Congress. Senate. Committee on Finance
- Language: English
- Number of Pages: Median: 177
- Publisher: U.S. G.P.O.
- Publish Date: 2011
- Publish Location: Washington
“Staff report on Sanofi's strategic use of third parties to influence the FDA” Subjects and Themes:
- Subjects: ➤ Corrupt practices - Management - Drug approval - Anticoagulants (Medicine) - Government policy - Generic drugs - Sanofi aventis (Firm) - United States. Food and Drug Administration - United States
- Places: United States
Edition Identifiers:
- The Open Library ID: OL43926998M
- Online Computer Library Center (OCLC) ID: 741958525
Author's Alternative Names:
"United States Congress. Senate. Committee on Finance", "United States Congress. Senate. Committee on Finance.", "United States. Congress. Senate. Committee on Finance.", "[United States. Congress. Senate. Committee on Finance]", "United States Congress. Senate . Committee on finance", "United States. Congress. Senate. Committee of Finance." and "United States Congress. Senate . Committee on Finance"Access and General Info:
- First Year Published: 2011
- Is Full Text Available: No
- Is The Book Public: No
- Access Status: No_ebook
Online Access
Downloads Are Not Available:
The book is not public therefore the download links will not allow the download of the entire book, however, borrowing the book online is available.
Online Borrowing:
Online Marketplaces
Find Staff report on Sanofi's strategic use of third parties to influence the FDA at online marketplaces:
- Amazon: Audiable, Kindle and printed editions.
- Ebay: New & used books.
2L'usine de Vitry, 100 ans de Rhône-Poulenc à Sanofi
By Pierre Benacquista
“L'usine de Vitry, 100 ans de Rhône-Poulenc à Sanofi” Metadata:
- Title: ➤ L'usine de Vitry, 100 ans de Rhône-Poulenc à Sanofi
- Author: Pierre Benacquista
- Language: fre
- Number of Pages: Median: 272
- Publisher: les Points sur les i
- Publish Date: 2008
- Publish Location: Le Kremlin-Bicêtre
“L'usine de Vitry, 100 ans de Rhône-Poulenc à Sanofi” Subjects and Themes:
- Subjects: ➤ History - Chemical industry - Industries - Labor unions - Rhône-Poulenc (Firm) - Sanofi aventis (Firm)
- Places: France - Vitry-sur-Seine
Edition Identifiers:
- The Open Library ID: OL45204960M
- Online Computer Library Center (OCLC) ID: 758402413
- All ISBNs: 9782915640717 - 2915640718
Access and General Info:
- First Year Published: 2008
- Is Full Text Available: No
- Is The Book Public: No
- Access Status: No_ebook
Online Marketplaces
Find L'usine de Vitry, 100 ans de Rhône-Poulenc à Sanofi at online marketplaces:
- Amazon: Audiable, Kindle and printed editions.
- Ebay: New & used books.
Wiki
Source: Wikipedia
Wikipedia Results
Search Results from Wikipedia
Sanofi
Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product
Sanofi Pasteur
In 2004, Aventis merged with and into Sanofi. The new Sanofi-Aventis Group became the world's 3rd largest pharmaceutical company. Aventis Pasteur, the
List of pharmaceutical companies
acquired by Wesmarmers in 2022) Avax (bef. 2006– ) Avella (1996– ) Aventis (subsidiary of Sanofi; 1956– ) B. Braun (1839– ) Barkat (2010– ) Bausch & Lomb (subsidiary
Marion Merrell Dow
clientele. Aventis will abandon the campus by the end of 2006, following its worldwide reorganization. Collison, Kevin (August 28, 2009). "Sanofi-Aventis to close
Vijay Mallya
estate, and fertilizer. He was the chairman of Sanofi India (previously known as Hoechst AG and Aventis) and of Bayer CropScience in India for over 20
Proctosedyl
by Patheon Limited on behalf of the Sanofi-Aventis group. Manufacture and distribution is provided by Sanofi Aventis subsidiaries Hoechst and Hoechst Marion
Fortrea
provide Merck with genomic analysis services. In 2010, the company and Sanofi-Aventis created an outsourcing partnership, which, at the time was considered
Shook, Hardy & Bacon
Eli Lilly and Company, Amgen, Bristol-Myers Squibb, GlaxoSmithKline, Sanofi-Aventis, Guidant, and Wyeth. In 2007, Shook won a $69.5 million verdict on behalf
List of companies of France
This list shows firms in the Fortune Global 500, which ranks firms by total revenues reported before 31 March 2017. Only the top five firms (if available)
L'Oréal
Synthélabo merged with Sanofi in 1999 to become Sanofi-Synthélabo. Sanofi-Synthélabo merged with Aventis in 2004 to become Sanofi-Aventis. Nestlé has owned